Natera
NASDAQ: NTRAIncorporated in Delaware · 8 known investors
Natera develops genetic tests and diagnostics using cell-free DNA technology to detect diseases including cancers, genetic disorders, and transplant-related conditions. The company serves patients, physicians, and healthcare systems across oncology, women's health, and organ health.
BiotechDigital HealthHealthtechMedical Devices
Founders & leadership
MR
Matthew RabinowitzCo-founder & Executive Chairman
JS
Jonathan SheenainCo-Founder, Board Member
Investors · 8
Founder mafia
2 people who came through Natera went on to found or lead other companies.
Competitors · 5
by search overlapLabcorp1823 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Quest Diagnostics1331 shared keywordsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.
Myriad837 shared keywordsMyriad provides germline and tumor genomic testing across hereditary cancer, prenatal and reproductive health, prostate cancer, and pharmacogenomics for mental health medications. It supplies patients and healthcare providers with genetic screening results and AI-derived insights to inform diagnosis, risk assessment, and treatment decisions.
Nucleus Genomics771 shared keywordsNucleus provides genetic testing and analysis for couples planning pregnancy, screening for over 200 hereditary diseases, traits, and health conditions. For those undergoing IVF, the company offers embryo selection guidance to reduce disease risk and optimize traits including eye color, height, and intelligence.
Invitae741 shared keywordsInvitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life. Now part of Labcorp, the company leverages a nationwide network of patient service centers and coverage by most health plans to make genetic testing more accessible.
Companies competing with Natera for the same Google search keywords, organic and paid, via search-intersection analysis.
Acquisitions · 1
Early investors' stakes continue via these dealsForesight Diagnostics
Cancer recurrence testing platform acquired by Natera.
In the news
Natera (NTRA) Lands New Trial Partnerships, Is The Upside Already Priced In? - Simply Wall St Newssimplywall.st · Jul 2026Frequently asked questions
- What does Natera do?
- Natera develops genetic tests and diagnostics using cell-free DNA technology to detect diseases including cancers, genetic disorders, and transplant-related conditions. The company serves patients, physicians, and healthcare systems across oncology, women's health, and organ health.
- Who founded Natera?
- Natera was founded by Matthew Rabinowitz, Jonathan Sheena.
- Who are Natera's investors?
- Natera's investors include Bain Capital Life Sciences, Cheyenne Ventures, Claremont Creek Ventures, Foresite Capital, Harmony Partners, Lightspeed Venture Partners, RA Capital, Sofinnova Ventures.